Evidence map›Paper›PMID 37189719›Full record

ArticleBiomedicines2023

The eGFR Decline as a Risk Factor for Metabolic Syndrome in the Korean General Population: A Longitudinal Study of Individuals with Normal or Mildly Reduced Kidney Function.

Seung Hyun Han, Seung Ku Lee, Chol Shin, Sang Youb Han

Abstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Seung Hyun HanDepartment of Internal Medicine, Division of Nephrology, Inje University, Ilsan-Paik Hospital, Goyang 10380, Republic of Korea.
Seung Ku LeeInstitute of Human Genomic Study, Korea University Ansan Hospital, Ansan 15355, Republic of Korea.ORCID 0000-0001-5120-5557
Chol ShinInstitute of Human Genomic Study, Korea University Ansan Hospital, Ansan 15355, Republic of Korea.
Sang Youb HanDepartment of Internal Medicine, Division of Nephrology, Inje University, Ilsan-Paik Hospital, Goyang 10380, Republic of Korea.ORCID 0000-0003-3312-0597

Funding

Korea Disease Control and Prevention Agency 2005-E71001-00, 2006-E71005-00, 2006-E71006-00, 2007-E71001-00, 2007-E71003-00, 2008-E71001-00, 2008-E71005-00, 2009-E71002-00, 2009-E71007-00, 2010-E71001-00, 2010-E71004-00, 2011-E71004-00, 2011-E71008-00, 2012-E71005-00, 2012-E71008-00, 2013-E71005-00,Korea Disease Control and Prevention Agency 2013-E71007-00, 2014-E71003-00, 2014-E71005-00, 2015-P71001-00, 2015-E71002-00, 2016-E71003-00 , 2016-E71002-00, 2017-E71001-00, 2017-E71002-00, 2018-E7101-00, 2018-E7102-00, 2019-E7104-00, 2019-E7105-00, 2019-E7104-01, 2019-E7105-01National Research Foundation of Korea 2022R1A2C1005430
6 · The paper itself

Abstract

Metabolic syndrome (MS) is a risk factor for the development and progression of chronic kidney disease (CKD). However, it is unclear whether decreased renal function affects MS. Through a longitudinal study, we investigated the effect of estimated glomerular filtration rate (eGFR) changes on MS in participants with an eGFR above 60 mL/min/1.73 m

Indexed as

eGFRgeneral populationkidneymetabolic syndrome

Identifiers

PMID37189719
PMCPMC10135887

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.